» Authors » Brendan McCormick

Brendan McCormick

Explore the profile of Brendan McCormick including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 34
Citations 203
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Khan W, Oliver M, Crabtree J, Clarke A, Armstrong S, Fox D, et al.
Am J Kidney Dis . 2024 Mar; 84(2):195-204.e1. PMID: 38447707
Rationale & Objective: A history of prior abdominal procedures may influence the likelihood of referral for peritoneal dialysis (PD) catheter insertion. To guide clinical decision making in this population, this...
2.
Qureshi M, Maierean S, Crabtree J, Clarke A, Armstrong S, Fissell R, et al.
Clin J Am Soc Nephrol . 2024 Jan; 19(4):472-482. PMID: 38190176
Background: This study investigated the association of intra-abdominal adhesions with the risk of peritoneal dialysis (PD) catheter complications. Methods: Individuals undergoing laparoscopic PD catheter insertion were prospectively enrolled from eight...
3.
Deacon E, Canney M, McCormick B, Ramsay T, Biyani M, Brown P, et al.
Kidney Int Rep . 2023 Dec; 8(12):2646-2653. PMID: 38106569
Introduction: Intraperitoneal (IP) vancomycin is often first-line empiric therapy and then maintenance therapy for peritoneal dialysis (PD) peritonitis. However, how vancomycin serum levels correlate with clinical outcomes remains unclear. Methods:...
4.
Chan R, McCudden C, McCormick B, Zimmerman D
Can J Kidney Health Dis . 2023 Jun; 10:20543581231177841. PMID: 37313364
Rationale: The differential diagnosis for a patient with high-anion-gap metabolic acidosis (HAGMA) is broad; lactic acidosis is an important entity to screen for and treat. An elevated serum lactate is...
5.
Cosmatos A, McCormick B, Blew B, Brown P
Can J Kidney Health Dis . 2023 Feb; 10:20543581231156854. PMID: 36814965
Rationale: Clear guidelines currently exist regarding antibiotic prophylaxis for patients on peritoneal dialysis (PD) prior to common diagnostic procedures. However, these guidelines do not include patients with subcutaneously embedded PD...
6.
Deacon E, Canney M, McCormick B, Brown P, Biyani M, Zimmerman D
Perit Dial Int . 2022 Nov; 43(1):45-52. PMID: 36350011
Background: Intraperitoneal (IP) vancomycin is often first-line empiric therapy for peritoneal dialysis (PD) peritonitis; however, whether dosing should be adjusted for patient-specific characteristics remains unclear. We sought to identify factors...
7.
Farfan-Ruiz A, Czikk D, Leidecker J, Ramsay T, McCormick B, Wilson K, et al.
Kidney360 . 2022 Apr; 2(2):290-297. PMID: 35373021
Background: Hyperphosphatemia is almost universal in well-nourished patients with ESKD treated with dialysis due to an imbalance between dietary intake and phosphate removal via residual kidney function and dialysis. Although...
8.
Cosmatos A, McCormick B, Brown P
Perit Dial Int . 2021 Dec; 42(4):425-427. PMID: 34931556
Peritoneal dialysis (PD) is as safe and more cost-effective than haemodialysis (HD). It also allows patients to undergo renal replacement therapy (RRT) from home. However, PD remains underutilised in many...
9.
Alabbas A, Harvey E, Kirpalani A, Teoh C, Mammen C, Pederson K, et al.
Can J Kidney Health Dis . 2021 Nov; 8:20543581211053458. PMID: 34777841
Purpose Of The Program: This article provides guidance on optimizing the management of pediatric patients with end-stage kidney disease (ESKD) who will be or are being treated with any form...
10.
Copland M, Hemmett J, MacRae J, McCormick B, McCormick M, Qirjazi E, et al.
Can J Kidney Health Dis . 2020 Jun; 7:2054358120928153. PMID: 32523709
Purpose Of Program: This paper will provide guidance on how to best manage patients with end-stage kidney disease who will be or are being treated with home dialysis during the...